Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-103568-4   |   PDF   |   Print   |  
published: 01 Jun 2012 last updated: 31 Jul 2020
General Information
6786-01-0160 (adv. 42010.0160); Summary of the risk assessment of a deliberate release (field trial) of genetically modified potatoes (Solanum tuberosum, variety Albatros)  transformed with plasmids pCB301-Kan-MaSpI-100xELP, pCB301-Kan-MaSpII-100xELP and pCB301-Kan-SO1-100xELP, issued by the German Competent Authority
EN
10 May 2005
Risk assessment details
  • Potato modified to synthesise fusion spider silk/ elastin protein
    | Resistance to antibiotics (Kanamycin), Use in industrial applications
  • Potato modified for the production of spider silk protein
    | Production of medical or pharmaceutical compounds (human or animal), Resistance to antibiotics (Kanamycin), Use in industrial applications
  • Potato modified to synthesise fusion spider silk fragment/ elastin protein
    | Resistance to antibiotics (Kanamycin), Use in industrial applications
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
One field site in Germany, for details refer to the German LMO/GMO location register (German language only) (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
construct specific PCR-based method
EN
Loading...